Why was a director part funding a purchase of a house with shares a kick in the teeth? I don't get it, but I'm fed up of hearing about it that's for sure
1. BAMS validation complete 2. AVA6000 submission for patient trials 3. Expanded manufacturing for LFT in the far East 4. BBI complete first 10k validation batch 5. Stem cell treatment update in Korea.
Negative reasons where an RNS will be required 1. BAMS failed validation 2. BBI fail tech transfer and give up
So what's all the worry about? We've had no RNS on any of the Q4 news either negative or positive.
We've had plenty of speculation, guessing and to be frank blatantly lying but no official news.
I know this is a discussion board but there really is nothing new to discuss. We have been told numerous times what the state of play is. So perhaps waiting for the RNS that will be released when the 10k validation batch is ready is the best thing to do.
In the meantime the impatient and traders will drift away looking for some profit elsewhere.
It's not us until the 10k pilot batch is complete!
There will be an RNS to confirm this as the company has stated all along and restated in the Q&A:
The Company has also stated that it will provide the next update to the market on the lateral flow test, including a timeline to clinical validation and CE marking, when the first pilot batch goes into production.
4% down over the week but who cares when we have BAMS validated and that 10k pilot batch ready we will look back on globals share price predictions and have a ruddy good laugh!!! Oh wait, we do already.......
Stop now, it's bizzare how a sale of 4% of shares has caused probably thousands of posts. All attempting to disrupt and deramp. Probably for a lower entry.
Nothing has changed with regard to test development and validation. Only that we are a week closer.